Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7317 p399
18 September 2004


Society summary


BPC session for students to throw spotlight on careers in pharmacy

British Pharmaceutical Conference 2004Career opportunities in pharmacy are to be the theme of a special programme for students at this year’s British Pharmaceutical Conference on the afternoon of Wednesday 29 September.

The programme for the session, which was finalised this week, will take the form of a series of 15- to 20-minute addresses examining pharmacy career opportunities in a number of areas, including primary care, community, hospital, industry and government. There will also be advice for those aiming to start up their own pharmacy businesses.

The session will be chaired jointly by Duncan Craig, head of pharmacy in the school of chemical sciences and pharmacy at the University of East Anglia, and Tommy Dolan, group director, pharmaceutical research and development, at Pfizer.

After a chairmen’s introduction by Professor Craig and Dr Dolan at 1.45pm, the following talks will be given:

· 2pm, “Industry (research and development): developing tomorrow’s medicines” by Julie Cahill, senior pharmaceutical scientist, AstraZeneca
· 2.15pm, “Academia: moulding the next generation of pharmacists” by Yvonne Perrie, lecturer in pharmaceutics, Aston University
· 2.30pm, “Primary care trusts: managing the many interfaces in health care” by Janet Corbett, pharmaceutical adviser, Milton Keynes Primary Care Trust
· 2.45pm, “The PhD experience” by Myrto Xyloyiannis, Aphton Corporation.
· 3.20pm, “Community pharmacy: the first point of call for the patient” by Noel Wicks, director, Advanced Complementary Medicine Services Ltd, and a member of the Society’s Council
· 3.35pm “Industry (regulatory affairs): taking medicines to the market” by Aileen Fischer, Pfizer
· 3.50pm “Hospital pharmacy: at the heart of the health care team” by Lyn Hanning, South-West Medicines Information and Training, Bristol Royal Infirmary
· 4.05pm, “Starting your own company: greed is good” by Navid Malik, Williams de Broë Plc (investment bank)
· 4.20pm, “Working as a pharmacist in a government agency: Medicines and Healthcare products Regulatory Agency” by Sarah Branch, post-licensing assessment group, MHRA.

The session concludes at 4.35pm with a 25-minute panel discussion.

Gill Hawksworth, chairman of the BPC Conference Committee, said: “This special session for students is a new initiative for BPC and we are delighted by the level of support it has already received. We hope that by encouraging students to attend BPC we can sow the seeds for a future generation of delegates.”

Ruth Duncan, Science Chairman for BPC 2004, said: “Rapid progress towards innovative therapies for improved treatment of life-threatening and debilitating diseases lies in the hands of the current and the next generation of pharmaceutical scientists. As all pharmacy undergraduate students now undertake a masters degree, I am particularly delighted that they will be attending BPC 2004, not only to learn more of the opportunities open for their own career development, but also to share all their exciting and inventive ideas for future medicines research.”

A special day rate of £5 + VAT is available for students attending BPC on 29 September. Places are limited and early booking via the BPC website at www.bpc2004.org is advised.

Back to Top


©The Pharmaceutical Journal